ArticleComputers in biology and medicine2023
A fuzzy fine-tuned model for COVID-19 diagnosis.
Article in Computers in biology and medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Linguistic summarization of visual attention and developmental functioning of young children with autism spectrum disorder.Health information science and systems · 2024Article
- FACNN: fuzzy-based adaptive convolution neural network for classifying COVID-19 in noisy CXR images.Medical & biological engineering & computing · 2024Article
- CCTCOVID: COVID-19 detection from chest X-ray images using Compact Convolutional Transformers.Frontiers in public health · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The COVID-19 disease pandemic spread rapidly worldwide and caused extensive human death and financial losses. Therefore, finding accurate, accessible, and inexpensive methods for diagnosing the disease has challenged researchers. To automate the process of diagnosing COVID-19 disease through images, several strategies based on deep learning, such as transfer learning and ensemble learning, have been presented. However, these techniques cannot deal with noises and their propagation in different layers. In addition, many of the datasets already being used are imbalanced, and most techniques have used binary classification, COVID-19, from normal cases. To address these issues, we use the blind/referenceless image spatial quality evaluator to filter out inappropriate data in the dataset. In order to increase the volume and diversity of the data, we merge two datasets. This combination of two datasets allows multi-class classification between the three states of normal, COVID-19, and types of pneumonia, including bacterial and viral types. A weighted multi-class cross-entropy is used to reduce the effect of data imbalance. In addition, a fuzzy fine-tuned Xception model is applied to reduce the noise propagation in different layers. Quantitative analysis shows that our proposed model achieves 96.60% accuracy on the merged test set, which is more accurate than previously mentioned state-of-the-art methods.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.